Tissue-specific estrogenic response and molecular mechanisms
1Deutsche Sporthochschule Köln, Institute of Morphology and Tumor Research, Carl-Diem-Weg 6, 50927 Cologne, Germany. diel@hrz.dshs-koeln.de
Abstract:
Estrogens exert profound effects on growth, differentiation, and function of many reproductive tissues. They also affect other tissues, including bone, liver, cardiovascular system, and brain. In the last few years it has been demonstrated that several synthetic estrogens can act in a tissue-specific manner. The first example of such a selective estrogen receptor modulator (SERM) was tamoxifen, for which an estrogen agonist-like activity in the endometrium and bone was seen to occur simultaneously with an estrogen antagonist activity in the breast. The mechanisms by which the same compound can exert tissue-specific agonist and antagonist actions are still being investigated. Important aspects include the interaction of the ligand with the two estrogen receptor subtypes and the interaction of these ligand-receptor complexes with effectors, which include different DNA response elements and important coregulator proteins. In addition to well-documented effects on gene transcription, there is evidence that estrogen receptors and other estrogen binding proteins are involved in some rapid, non-genomic effects of estrogens in target cells. For these reasons it is important to point out that a toxicological evaluation of endocrine modulators should include an analysis of potential SERM-like properties.
Insights
Selective estrogen receptor modulators (SERMs) like tamoxifen exhibit tissue-specific effects, acting as agonists in some tissues and antagonists in others. Understanding these complex mechanisms is crucial for evaluating endocrine-modulating drugs.
Area of Science:
- Endocrinology
- Molecular Biology
- Toxicology
Background:
- Estrogens significantly impact reproductive tissues, bone, liver, cardiovascular system, and brain.
- Synthetic estrogens can display tissue-specific actions, a property exemplified by selective estrogen receptor modulators (SERMs).
Purpose of the Study:
- To explore the mechanisms underlying tissue-specific agonist and antagonist activities of SERMs.
- To highlight the importance of evaluating SERM-like properties in toxicological assessments of endocrine modulators.
Main Methods:
- Investigating ligand interactions with estrogen receptor subtypes.
- Analyzing ligand-receptor complex interactions with DNA response elements and coregulator proteins.
- Considering both genomic and rapid non-genomic effects of estrogens.
Main Results:
- Tamoxifen, a pioneering SERM, demonstrates estrogen agonist activity in the endometrium and bone, concurrently with antagonist activity in breast tissue.
- The complexity of SERM action involves differential interactions with estrogen receptor subtypes and associated cellular machinery.
Conclusions:
- The same compound can elicit distinct tissue-specific responses, acting as both an agonist and antagonist.
- Thorough toxicological evaluation of endocrine modulators must incorporate the assessment of potential SERM-like properties to ensure comprehensive safety analysis.
Related Concept Videos
01:13Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
01:25Dose-Response Relationship: Selectivity and Specificity
01:12Elastin is Responsible for Tissue Elasticity
Ligaments and tendons are made of dense regular connective tissue, but in ligaments not all fibers are parallel. Dense regular elastic tissue contains elastin fibers and...
03:06Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
03:51Molecular Orbital Theory II
02:35Molecular Orbital Theory I